Anyone
reading the business pages recently could not fail to notice that international
private-equity companies see India as their favourite destination.
And there is one sector that stands out:
medical services.
The headlines prove it: Jardine Rothschild
Asia Capital to make $40 million investment in Quality Care; or General
Atlantic in talks over a $100m deal to buy DM Healthcare; or Aureos Capital
invests $10m in BSR Super Speciality Hospitals.
Such investments came into vogue last year,
and this year is shaping up to produce an equal number of deals, if not more.
Venture Intelligence, based in Mumbai,
recently published a study detailing private-equity deal flows and predicted
trends for this year.
"Our survey found that health care is the
sector that investors expect to prefer the most in 2012. We expect the strong
pace of investments in this sector to continue," said Arun Natarjan, the
chief executive of Venture Intelligence.
Nervousness in the global market is driving
investors away from initial public offerings (IPOs) and towards buyouts
instead, he adds.
"The same survey also indicated an uptick
in overall investment activity during 2012 - encouraged by the attractive
valuations to be had in the current scenario, with public markets being shaky
and not welcoming to new IPOs," Mr Natarjan says.
Already for this year, there is estimated to
be more than US$2 billion (Dh7.34bn) in private-equity funds earmarked for the
healthcare sector, the research noted.
Secondary buyouts will dominate this year,
said N Muthuraman, the director of RiverBridge Investment Advisors.
"In the short term, secondary buyouts are
more likely to happen as many funds may reach maturity this year without any
other exit in sight. This could have a sobering effect on the valuations, as
secondary transactions are typically done at lower multiples than IPOs,"
he said.
The headlines are hardly surprising if you
consider the sector's potential. The value of India's healthcare industry was
pegged at close to $50bn in 2010 and has been growing at an average annual rate
of 17 per cent over the past five years, according to India Brand Equity
Foundation.
India needs everything from ambulances to
clinical equipment, hospitals to vaccines. The public sector is suffering
enormously from crowding, low public spending and poor infrastructure.
"India's expenditure on health care is
much below global averages," said Gawir Baig, associate vice president of
O3 Capital, an investment banking company.
"India's share in the global disease
burden is 20 per cent, but its share of healthcare infrastructure is much
lower, with only 6 per cent share of global hospital beds and 8 per cent share
of doctors and nursing staff. Public expenditure on healthcare in India is also
unusually low."
The government cannot cope with the increasing
burden, which means most of the gap will be filled by the private sector. But
there are other growth drivers, too.
"India is a very nascent market. There
are supply-side constraints, which adds to the growth potential," says Mr
Baig. "In addition, there are macroeconomic factors, which provide an
additional boost to the Indian healthcare space, such as rising income levels,
increase in life expectancy and incidence of lifestyle disease."
Basic care - or primary health care - is the
area to watch, as 80 per cent of all health requirements fall in this category.
This category accounts for 60 per cent of the healthcare market and is growing
at an average annual rate of 15 per cent. The market is worth $30bn but is
likely to reach $200bn to $250bn by 2025, according to Technopak Advisors, a
research house.
Primary care aside, there are opportunities in
diagnostics, ambulance services and equipment maintenance, dental care, and
daycare facilities, says KPMG, a global consultancy.
More than 80 per cent of India's health care
is private, and companies have invested heavily in state-of-the-art equipment
and methods to remain competitive. The cost of being treated in India is still
very low, and as a result millions of foreigners go there for care.
Consequently, medical tourism is another
driver of growth of the Indian healthcare sector. It is predicted to become a
$100bn industry this year, according to a report by the research agency Frost
& Sullivan.
It all sounds very positive. But, as with
everything in India, there are snags. Any deal-making could be brought down by
government red tape.
"There are still regulatory changes
happening in certain sectors [such as pharmaceutical]," says Mahadevan
Narayanamoni, a partner in corporate finance at Grant Thornton India, an audit,
tax and advisory firm. "Regulatory uncertainties and delay in governmental
decision-making are impacting the speed at which [venture capital and private
equity] investments are happening."
A dearth of suitable targets is also a
potential problem.
"One of the major challenges for
private-equity investors in India has been the short supply of good deals. And
that has really not changed," Mr Narayanamoni says.
"As new sectors have gained prominence
such as e-commerce, education, clean-tech and health care, some traditional
favourites are not that favoured any more such as infrastructure, retail and
financial services," he says.
While the private-equity players may well be sharpening
their teeth for their next bite, the IPO pipeline is expected to remain dry.
"We don't see any of the mid-size players
doing an IPO, given the sentiments on the IPO markets for 2012, and none of the
mid-sized healthcare companies have crossed the $100m to $125m threshold
turnover to make it an ideal candidate for a public issue," says Mr Baig.
Pia Heikkila
The National
Top
5: Private-equity medical services deals
Global
Hospitals US$116 million (Dh426m) from Samsara Capital,
June 2007. Global Hospitals in Hyderabad has operated for more than 10 years.
It began as a 150-bed facility in 1998 but by 2009 the group had 2,000 beds in
multiple locations in Bangalore and Chennai. The company is planning to open
facilities in Mumbai, Kolkata, New Delhi and Bhubaneswar. It offers speciality
care, a multi-organ transplant hospital and combines research, teaching and
patient care.
Max
India Max India has ventured into businesses across
the healthcare and health-insurance sectors. Today, it has more than 400
locations across the country and a workforce of 57,000. The deal was done via
convertible debentures, and Goldman took about 9.4 per cent equity capital in
the company. Goldman also gained a seat on the board, reports said.
Apollo
Hospitals Enterprise $104m from Apax,
September 2007. Apollo was founded in 1983 in Chennai as a 150-bed hospital.
Today, the group is one of Asia’s largest healthcare companies, with 8,500 beds
in 54 hospitals in India. Apax Partners, based in London, took 11.5 per cent in
Apollo Hospitals for $104m through a share issue. Apollo has other major
foreign backers including Bank of New York, Bisikan Bayu Investments Mauritius,
FID Funds and Emerging Markets Growth Fund.
Narayana
Hrudayalaya $100m JPMorgan and AIG, February 2008. The
company, founded in 1999 in Kolkata, is a subsidiary of one of one of India’s
oldest construction companies, Shankar Narayana Construction. The group has
5,000 beds in India and aims to have 30,000 beds in the next five years.
Metropolis
Healthcare $85m from Warburg Pincus, June 2010. The
company was founded in 1981 in Mumbai and today it has diagnostics centres in
the UAE, Sri Lanka, Thailand and South Africa. It processes more than 10
million medical tests a year. It received $85m from Warburg Pincus.
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.
No comments:
Post a Comment